1.Iron deposition in subcortical nuclei of Parkinson's disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies.
Jianing JIN ; Dongning SU ; Junjiao ZHANG ; Joyce S T LAM ; Junhong ZHOU ; Tao FENG
Chinese Medical Journal 2025;138(6):678-692
BACKGROUND:
Iron deposition plays a crucial role in the pathophysiology of Parkinson's disease (PD), yet the distribution pattern of iron deposition in the subcortical nuclei has been inconsistent across previous studies. We aimed to assess the difference patterns of iron deposition detected by quantitative iron-sensitive magnetic resonance imaging (MRI) between patients with PD and patients with atypical parkinsonian syndromes (APSs), and between patients with PD and healthy controls (HCs).
METHODS:
A systematic literature search was conducted on PubMed, Embase, and Web of Science databases to identify studies investigating the iron content in PD patients using the iron-sensitive MRI techniques (R2 * and quantitative susceptibility mapping [QSM]), up until May 1, 2023. The quality assessment of case-control and cohort studies was performed using the Newcastle-Ottawa Scale, whereas diagnostic studies were assessed using the Quality Assessment of Diagnostic Accuracy Studies-2. Standardized mean differences and summary estimates of sensitivity, specificity, and area under the curve (AUC) were calculated for iron content, using a random effects model. We also conducted the subgroup-analysis based on the MRI sequence and meta-regression.
RESULTS:
Seventy-seven studies with 3192 PD, 209 multiple system atrophy (MSA), 174 progressive supranuclear palsy (PSP), and 2447 HCs were included. Elevated iron content in substantia nigra (SN) pars reticulata ( P <0.001) and compacta ( P <0.001), SN ( P <0.001), red nucleus (RN, P <0.001), globus pallidus ( P <0.001), putamen (PUT, P = 0.021), and thalamus ( P = 0.029) were found in PD patients compared with HCs. PD patients showed lower iron content in PUT ( P <0.001), RN ( P = 0.003), SN ( P = 0.017), and caudate nucleus ( P = 0.017) than MSA patients, and lower iron content in RN ( P = 0.001), PUT ( P <0.001), globus pallidus ( P = 0.004), SN ( P = 0.015), and caudate nucleus ( P = 0.001) than PSP patients. The highest diagnostic accuracy distinguishing PD from HCs was observed in SN (AUC: 0.85), and that distinguishing PD from MSA was found in PUT (AUC: 0.90). In addition, the best diagnostic performance was achieved in the RN for distinguishing PD from PSP (AUC: 0.86).
CONCLUSIONS:
Quantitative iron-sensitive MRI could quantitatively detect the iron content of subcortical nuclei in PD and APSs, while it may be insufficient to accurately diagnose PD. Future studies are needed to explore the role of multimodal MRI in the diagnosis of PD.
REGISTRISION
PROSPERO (CRD42022344413).
Humans
;
Parkinson Disease/diagnostic imaging*
;
Magnetic Resonance Imaging/methods*
;
Iron/metabolism*
2.Genome-wide DNA methylation and mRNA transcription analysis revealed aberrant gene regulation pathways in patients with dermatomyositis and polymyositis.
Hui LUO ; Honglin ZHU ; Ding BAO ; Yizhi XIAO ; Bin ZHOU ; Gong XIAO ; Lihua ZHANG ; Siming GAO ; Liya LI ; Yangtengyu LIU ; Di LIU ; Junjiao WU ; Qiming MENG ; Meng MENG ; Tao CHEN ; Xiaoxia ZUO ; Quanzhen LI ; Huali ZHANG
Chinese Medical Journal 2025;138(1):120-122
3.The study of the potassium ion channel Kv 3 .4 in buccal mucosa carcinogenesis of rat
Chengcheng SONG ; Junjiao ZHOU ; Baoqin WU ; Minhai NIE
Chongqing Medicine 2014;(15):1837-1839
Objective To investigate the expression of the Kv3 .4 protein and Kv3 .4 mRNA in various stages of oral carcino‐genesis .Methods The expression of Kv3 .4 protein and Kv3 .4 mRNA were detected by immunohistochemistry (SP method) and RT‐PCR technique respectively in the oral carcinogenesis of SD rat which were induced by 4NQO .Results With the aggravation of the epithelial dysplasia ,Kv3 .4 protein and Kv3 .4 mRNA expression increased gradually .They were strongly positive in oral squa‐mous cell carcinoma .Conclusion The expression of Kv3 .4 protein and Kv3 .4 mRNA levels increased consistently with the aggra‐vation of the epithelial dysplasia .
4.The clinical value of CA125 detection in ovarian endometriosis cyst
Chinese Journal of Primary Medicine and Pharmacy 2013;20(20):3109-3111
Objective To explore the application value of CA125 detection in the diagnosis and treatment of ovarian endometriosis cyst,to provide a reference for clinical diagnosis and treatment.Methods 51 patients with ovarian endometriosis cyst were selected as the observation group,and 51 patients with non endometriosis of benign ovarian cyst were selected as control group.The serum CA125 level was detected and compared between the two growps.Results Before operation,the serum CA125 level of the observation group was (95.29 ± 55.47) U/ml,which was significantly higher than that of the control group (17.96 ± 6.82) U/ml (P < 0.05).In the observation group,serum CA125 level of patients with endometriosis clinical pathological stage Ⅱ-Ⅳ was significantly higher than that of patients with stage Ⅰ (P < 0.05).The endometriosis clinical TNM stage was positively correlated with preoperative serum CA125 level in the observation group (r =0.8795,P < 0.05).The preoperative serum CA125 level in patients with dysmenorrhea score 1 point,2 points,3 points was significantly higher than that in patients with dysmenorrhea score 0 point (P < 0.05).The preoperative serum level of CA125 was positively correlated with dysmenorrhea score in the observation group (r =0.5594,P < 0.05).Conclusion The detection of serum carbohydrate antigen CA125 level has important value in diagnosis,treatment and prognosis of ovarian endometriosis.

Result Analysis
Print
Save
E-mail